Articles > Journals > Business and Economics journals > Investrend news wires > September 2009

Article: XOMA Announces $6 Million Antibody Discovery Collaboration.

Article from:
Investrend
Article date:
September 14, 2009
Copyright

Sep 14, 2009 (FinancialWire via COMTEX) -- (Comment on this article at http://www.financialwire.net/2009/09/14/xoma-announces-6-million-antibody-discovery-collaboration-2/)

September 14, 2009 (FinancialWire) -- XOMA Ltd. (NASDAQ: XOMA) and Arana Therapeutics Ltd., a wholly-owned subsidiary of Cephalon, Inc. (NASDAQ: CEPH), have entered into a collaboration involving multiple proprietary XOMA antibody research and development technologies, including a new antibody phage display library, and a suite of integrated information and data management systems.

Arana has agreed to pay XOMA a fee of $6 million and XOMA will be entitled to milestone payments and ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: XOMA Announces $6 Million Antibody Discovery ...
Investrend;  September 11, 2009 ;     700+ words ... ... Comment on this article at http://www.financialwire.net/2009/09/11/xoma-announces-6-million-antibody-discovery-collaboration/) September 11, 2009 (FinancialWire) -- XOMA Ltd. (NASDAQ: XOMA) and Arana Therapeutics ...

Article: XOMA To Present At Needham Life Sciences ...
Investrend;  June 8, 2009 ;     672 words ... ... Comment on this article at http://www.financialwire.net/2009/06/08/xoma-to-present-at-needham-life-sciences-conference/) June 8, 2009 (FinancialWire) -- XOMA Ltd. (NASDAQ: XOMA), a leader in the ...

Article: XOMA To Sell 10.4 Units.
Investrend;  June 9, 2009 ;     700+ words ... ... Comment on this article at http://www.financialwire.net/2009/06/09/xoma-to-sell-104-units/) June 9, 2009 (FinancialWire) -- XOMA Ltd. (NASDAQ: XOMA) has entered into ...

Article: XOMA Presents Info Showing Improvement In Diabetes, ...
Investrend;  June 11, 2009 ;     700+ words ... ... Comment on this article at http://www.financialwire.net/2009/06/11/xoma-presents-info-showing-improvement ... inflamatory-measures/) June 11, 2009 (FinancialWire) -- XOMA Ltd. (NASDAQ: XOMA), a leader in the ...

Article: XOMA Ltd. (Nasdaq:XOMA) Hot Stock on the Move!
M2 Presswire;  May 12, 2009 ;     700+ words ... ... PRESSWIRE-12 May 2009-PennyStockChaser.com: XOMA Ltd. (Nasdaq:XOMA) Hot Stock on the Move!(C)1994-2009 M2 COMMUNICATIONS ... com/join-now/ Today's news alerts include: XOMA Issued New U.S. Patent Covering Its XOMA 052 Lead ...

Article: XOMA Provides Clinical Plan Update On Diabetes Drug ...
GlobeNewswire;  December 10, 2008 ;     700+ words ... ... Dec 10, 2008 (GlobeNewswire via COMTEX) -- XOMA Ltd. (Nasdaq:XOMA) announced that it has accelerated its plans to initiate ... Phase 2 clinical trial of its antibody drug candidate, XOMA 052, for the treatment of Type 2 diabetes, in the ...

Article: XOMA Expands Claims Against Biosite; Alleges that Biosite ...
Business Wire;  June 3, 2002 ;     700+ words ... ... BERKELEY, Calif.--(BW HealthWire)--June 3, 2002 XOMA Ltd. (Nasdaq:XOMA) announced today that it has filed an amended and ... expression technology continues willfully to infringe XOMA's patents and that Biosite's statements regarding ...

Article: XOMA Announces Senior Management Appointments.
Business Wire;  January 12, 2006 ;     700+ words ...BERKELEY, Calif. -- XOMA Ltd. (Nasdaq:XOMA), a leading biopharmaceutical company in therapeutic antibodies ... generation platform and development capabilities and in establishing XOMA as the premier antibody discovery and development company ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives